In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a modest gain. At the time of writing, the benchmark index is up 0.2% to 8,631.7 points.
Four ASX shares that have failed to follow the market higher today are listed below. Here's why they are falling:
Image source: Getty Images
Brightstar Resources Ltd (ASX: BTR)
The Brightstar Resources share price is down 4% to 41.7 cents. This appears to have been driven by the gold miner issuing almost 245 million new shares this morning. Last month, Brightstar Resources announced a strategic $180 million capital raising to fund a material increase in production. Brightstar's managing director, Alex Rovira, said: "To emerge with all the equity funding required to build our Goldfields Hub, as well as a substantial budget that enables accelerated pre-development activities at Sandstone and to fully fund Sandstone to FID, is an amazing opportunity for Brightstar that enables us to maintain the momentum of de-risking our portfolio of advanced gold projects."
EQ Resources Ltd (ASX: EQR)
The EQ Resources share price is down 6.5% to 29 cents. This is despite the tungsten producer releasing an investor presentation this morning. Within the presentation, management stated: "EQR is one of the largest producers of tungsten outside of restricted countries, with spot-priced offtake agreements in place, supplying Europe, North America and Asian markets."
Novonix Ltd (ASX: NVX)
The Novonix share price is down almost 5% to 26.2 cents. This has been driven by news that the battery technology company's NASDAQ-traded shares could be delisted due to its weak share price. It advised: "The notice states that, for the previous 30 consecutive business days, the closing bid price of the Company's American Depositary Receipts (ADRs) listed on the Nasdaq has been below the minimum requirement of US$1.00 per ADR. In accordance with Nasdaq Listing Rules, the Company has 180 calendar days from the date of the notice to regain compliance (compliance period). To regain compliance, the closing bid price of the Company's ADR's must be at least US$1.00 per ADR for a minimum of 10 consecutive business days during the compliance period."
Pro Medicus Ltd (ASX: PME)
The Pro Medicus share price is down a further 2% to $125.40. This is despite there being no news out of the health imaging technology company. However, Pro Medicus' shares have been under pressure this year amid concerns over AI disruption. This has seen the Pro Medicus share price lose over 40% of its value since the turn of the year.
